<DOC>
	<DOCNO>NCT02963597</DOCNO>
	<brief_summary>The objective study evaluate effect continuous positive airway pressure ( PAP ) therapy pulmonary arterial ( PA ) pressure acute decompensated heart failure ( HF ) patient obstructive sleep apnea ( OSA ) . The study also assess change functional parameter , biomarkers , echocardiographic parameter .</brief_summary>
	<brief_title>Auto-PAP Pulmonary Hypertension Treatment Decompensated HF Patients With Sleep Apnea .</brief_title>
	<detailed_description>The ASAP-HF study prospective , randomize , control , two-center , study parallel group design , subject randomize either control ( APAP ) active treatment ( APAP ) 1:1 ratio . Group A ( active ) : standard medical therapy plus treatment continuous APAP 48hrs , Group B ( control ) : standard medical therapy . Many people heart failure ( HF ) also sleep-disordered breathing ( SDB ) , breathe irregularity sleep . These irregularity may interrupt sleep well increase rate progression Heart Failure . The ASAP-HF study do see certain clinical outcome improve acute decompensated heart failure ( HF ) patient SDB use non-invasive breathing device continuously short period time ( 48 hour ) patient still hospital . The device call AirSense™ 10 AutoSet ( AutoSet ) . It consist air flow generator , air tubing , air humidifier , mask . As patient breathe mask , AutoSet monitor breathe . The primary objective pilot study evaluate effect continuous positive airway pressure ( PAP ) therapy pulmonary arterial ( PA ) pressure acute decompensated heart failure ( HF ) patient obstructive sleep apnea ( OSA ) . The study also assess change functional parameter , biomarkers , echocardiographic parameter . This device currently use diagnose sleep apnea utility well study . This study establish utility device diagnose sleep apnea .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>1 . Age 18 year 2 . Decompensated Congestive Heart Failure systolic Pulmonary Artery pressure ≥50 mmHg ( include Right Atrial pressure ) 3 . Prior clinical diagnosis heart failure 4 . Moderate Severe predominately obstructive sleep disorder breathing document polygraphy Apnea Hypopnea Index ( AHI ) ≥20e/h 5 % time spend &lt; 90 % O2 Sat ( minimum 2hr recording time ) 5 . Patient able fully understand study information sign inform consent 1 . Chronic renal insufficiency ( Hemodialysis serum creatinine &gt; 2 ) 2 . Hemodynamically significant valvular disease 3 . Severe arthritis inability complete 6 Minute Walk Test 4 . Left Ventricular Assist Device/ heart transplant hemodynamically unstable 5 . Patient take Pulmonary vasodilator , include home oxygen . 6 . Known diagnosis Obstructive Sleep Apnea ( OSA ) active therapy 7 . 80 % respiratory event central/CheyneStokes breathe 8 . Recent cardiac surgery ( within 30 day admission ) 9 . Recent stroke ( within 30 day admission persistent neurological deficit ) 10 . Severe Chronic Obstructive Pulmonary Disease define forced expiratory volume one second ( FEV1 ) &lt; 50 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>